ICD-10 Code C86.01 | Extranodal NK/T-cell lymphoma, nasal type, in remission Symptoms, Diagnosis, Billing

Extranodal NK/T-cell lymphoma, nasal type, in remission is a rare and aggressive form of non-Hodgkin lymphoma characterized by the proliferation of natural killer (NK) cells. This condition primarily affects the nasal cavity and surrounding tissues, leading to significant morbidity. Accurate coding with ICD-10 Code C86.01 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.

What is ICD-10 Code C86.01 for Extranodal NK/T-cell lymphoma, nasal type, in remission?

ICD-10 Code C86.01 represents Extranodal NK/T-cell lymphoma, nasal type, in remission, indicating that the aggressive lymphoma has responded to treatment and is currently not active. This code is used in clinical documentation and billing to signify the patient's status, facilitating appropriate management and follow-up care while ensuring accurate reimbursement for healthcare services rendered.

ICD-10 Code C86.01 – Clinical Definition and Explanation of Extranodal NK/T-cell lymphoma, nasal type, in remission

Extranodal NK/T-cell lymphoma, nasal type, in remission is a hematological malignancy that arises from NK cells and typically presents with localized lesions in the nasal region. The condition can progress rapidly and requires prompt medical intervention. Its classification as 'in remission' indicates a favorable response to treatment, necessitating ongoing monitoring.

Key Clinical Features:

• Localized nasal obstruction or mass
• Epistaxis (nosebleeds)
• Facial swelling or pain
• Systemic symptoms such as fever or weight loss

ICD-10 Code C86.01 for Extranodal NK/T-cell lymphoma, nasal type, in remission – SOAP Notes & Clinical Use

ICD-10 Code C86.01 is utilized in SOAP notes to document the patient's clinical status, treatment response, and ongoing management of Extranodal NK/T-cell lymphoma, nasal type, in remission. This code aids in capturing relevant symptoms, assessments, and therapeutic interventions in both acute and chronic care settings.

What Does ICD-10 Code C86.01 for Extranodal NK/T-cell lymphoma, nasal type, in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C86.01 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of Extranodal NK/T-cell lymphoma, nasal type, in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C86.01 – Extranodal NK/T-cell lymphoma, nasal type, in remission

Management of Extranodal NK/T-cell lymphoma, nasal type, in remission focuses on monitoring for recurrence and managing any residual symptoms. Hospitalization may be necessary for severe cases or complications.

Antibiotic Therapy:

• Not applicable as this is not an infectious condition.

Supportive Care:

• Pain management with analgesics
• Nutritional support to maintain strength
• Psychosocial support for emotional well-being

Infection Control:

• Standard precautions to prevent infections during treatment
• Monitoring for signs of opportunistic infections

How to Document Symptoms of Extranodal NK/T-cell lymphoma, nasal type, in remission (ICD-10 C86.01) in SOAP Notes

Subjective:

• Patient reports nasal obstruction and occasional epistaxis.
• History of facial swelling that has improved since treatment.
• Denies fever or significant weight loss at this time.

Objective:

• Nasal examination reveals no active lesions.
• Facial swelling is noted to be reduced.
• Vital signs stable; no signs of systemic infection.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Extranodal NK/T-cell lymphoma, nasal type, in remission (ICD-10 Code C86.01)

Assessment:

• Extranodal NK/T-cell lymphoma, nasal type, in remission (ICD-10 Code C86.01).
• No current evidence of disease activity.
• Patient's symptoms are stable with no acute complications.

Plan:

• Continue monitoring with regular follow-up appointments.
• Educate patient on signs of recurrence and when to seek care.
• Consider imaging studies if symptoms reoccur.

Treatment & Plan Section for ICD-10 Code C86.01 – Extranodal NK/T-cell lymphoma, nasal type, in remission

• Regular follow-up appointments to monitor for recurrence.
• Supportive care measures to manage any residual symptoms.
• Patient education on recognizing signs of disease reactivation.
• Coordination with oncology for ongoing management.

Using ICD-10 Code C86.01 for Extranodal NK/T-cell lymphoma, nasal type, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and treatment response in SOAP notes.
• Use C86.01 in conjunction with relevant CPT codes for billing.
• Document any complications or comorbidities that may affect treatment.
• Align treatment plans with clinical guidelines to support justified billing.

Related ICD-10 Codes Often Used with Extranodal NK/T-cell lymphoma, nasal type, in remission

• C86.00 – Extranodal NK/T-cell lymphoma, unspecified type
• C83.19 – Other non-Hodgkin lymphoma, unspecified
• C85.90 – Non-Hodgkin lymphoma, unspecified

ICD-10 Code C86.01 in Medical Billing and Insurance for Extranodal NK/T-cell lymphoma, nasal type, in remission

ICD-10 Code C86.01 is crucial for accurate billing in hospital, ER, or infectious disease care settings, ensuring proper reimbursement for services related to Extranodal NK/T-cell lymphoma, nasal type, in remission.

Billing Notes:

• Document all relevant clinical findings and treatment responses to support claims.
• Use C86.01 in conjunction with appropriate CPT codes for comprehensive billing.
• Ensure that documentation reflects the patient's remission status clearly.

Common CPT Pairings: